Results 281 to 290 of about 14,968,498 (395)

Minutes, Arts & Sciences Student Life Committee, Tuesday, January 21, 2014 [PDF]

, 2014
Arts & Sciences Student Life Committee
core   +1 more source

PACIFIC NORTHWEST LABORATORY ANNUAL REPORT FOR 1968 TO THE USAEC DIVISION OF BIOLOGY AND MEDICINE. VOLUME I. LIFE SCIENCES. PART 1. BIOLOGICAL SCIENCES.

, 1970
Randall C. Thompson, Maria Stack, E.G. Swezea   +2 more
openalex   +2 more sources

Use of the reduced eye in life-science labs [PDF]

, 1980
Ann Jervie Sefton
openalex   +1 more source

Peripheral blood proteome biomarkers distinguish immunosuppressive features of cancer progression

Molecular Oncology, EarlyView.
Immune status significantly influences cancer progression. This study used plasma proteomics to analyze benign 67NR and malignant 4T1 breast tumor models at early and late tumor stages. Immune‐related proteins–osteopontin (Spp1), lactotransferrin (Ltf), calreticulin (Calr) and peroxiredoxin 2 (Prdx2)–were associated with systemic myeloid‐derived ...
Yeon Ji Park, Jae Won Oh, Hyewon Chung, Jung Won Kwon, Yi Rang Na, Kwang Pyo Kim, Seung Hyeok Seok   +6 more
wiley   +1 more source

Trends in scientific publishing: does quantity compromises quality in life sciences and medicine? [PDF]

Syst Rev
El Shamieh S, Chebly A.
europepmc   +1 more source

PACIFIC NORTHWEST LABORATORY ANNUAL REPORT FOR 1970 TO THE USAEC DIVISION OF BIOLOGY AND MEDICINE. VOLUME i. LIFE SCIENCES. PART 2. ECOLOGICAL SCIENCES.

, 1971
B.E. Vaughan
openalex   +2 more sources

Stochastic variation in the FOXM1 transcription program mediates replication stress tolerance

Molecular Oncology, EarlyView.
Cellular heterogeneity is a major cause of drug resistance in cancer. Segeren et al. used single‐cell transcriptomics to investigate gene expression events that correlate with sensitivity to the DNA‐damaging drugs gemcitabine and prexasertib. They show that dampened expression of transcription factor FOXM1 and its target genes protected cells against ...
Hendrika A. Segeren, Kathryn A. Wierenga, Frank M. Riemers, Elsbeth A. van Liere, Bart Westendorp   +4 more
wiley   +1 more source

Correction: An international consensus on effective, inclusive, and career-spanning short-format training in the life sciences and beyond. [PDF]

PLoS One
Williams JJ, Tractenberg RE, Batut B, Becker EA, Brown AM, Burke ML, Busby B, Cooch NK, Dillman AA, Donovan SS, Doyle MA, van Gelder CWG, Hall CR, Hertweck KL, Jordan KL, Jungck JR, Latour AR, Lindvall JM, Lloret-Llinares M, McDowell GS, Morris R, Mourad T, Nisselle A, Ordóñez P, Paladin L, Palagi PM, Sukhai MA, Teal TK, Woodley L.   +28 more
europepmc   +1 more source

PACIFIC NORTHWEST LABORATORY ANNUAL REPORT FOR 1970 TO THE USAEC DIVISION OF BIOLOGY AND MEDICINE. VOLUME I. LIFE SCIENCES. PART 1. BIOLOGICAL SCIENCES.

, 1971
R C Thompson
openalex   +2 more sources

Targeting PRAME directly or via EZH2 inhibition overcomes retinoid resistance and represents a novel therapy for keratinocyte carcinoma

Molecular Oncology, EarlyView.
The study evaluated the function and therapeutic implications of PRAME in basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). The findings demonstrate that PRAME impairs keratinocyte differentiation pathways. Furthermore, PRAME impairs anticancer response to retinoid compounds in BCC and SCC cells.
Brandon Ramchatesingh, Amelia Martinez Villarreal, Philippe Lefrançois, Jennifer Gantchev, Sriraam Sivachandran, Samy Abou Setah, Ivan V. Litvinov   +6 more
wiley   +1 more source